ATI RN · Pathophysiology · ATI Pathophysiology Quizlet

Option A: Streptococcus pneumoniae is the most likely cause of the findings in this patient, as the combination of high protein, low glucose, and numerous polymorphonuclear leukocytes in the cerebrospinal fluid is characteristic of bacterial meningitis, particularly that caused by this organism. Streptococcus pneumoniae is a common pathogen in adults presenting with these symptoms.

Option B: Neisseria meningitidis typically presents with similar CSF findings; however, it is more common in younger populations and often associated with a petechial rash, which is not mentioned in this case.

Option C: Escherichia coli is more commonly associated with neonatal meningitis and does not typically present with the classic triad of findings seen here in adults.

Option D: Listeria monocytogenes is also a potential cause of meningitis, particularly in immunocompromised individuals and the elderly, but it usually presents with a different CSF profile and is less common in a healthy 30-year-old male.

Takeaways: Understanding the CSF profile in meningitis is crucial, as the presence of high protein, low glucose, and PMNs strongly indicates bacterial infection, particularly from Streptococcus pneumoniae in adults.

Option B: Hypertrophy refers to the increase in cell size and function, often in response to increased workload or stress. This physiological adaptation can occur in various tissues, such as cardiac muscle, where cells enlarge to meet heightened demands, enhancing overall function.

Option A: Atrophy describes a decrease in cell size and function, typically due to disuse, aging, or decreased blood supply, leading to tissue shrinkage rather than growth.

Option C: Metaplasia involves the replacement of one differentiated cell type with another, often as an adaptive response to chronic irritation or injury, rather than an increase in cell size.

Option D: Hyperplasia signifies an increase in the number of cells in a tissue or organ, which can lead to enlargement, but does not imply an increase in the size of individual cells.

Takeaways: Understanding the distinction between hypertrophy, atrophy, metaplasia, and hyperplasia is crucial for accurate documentation and patient assessment, particularly in conditions requiring cellular adaptation and response to stressors.

Option C: Chloroquine phosphate (Aralen) is the appropriate medication to administer for the prevention of malaria, particularly in areas where the disease is endemic, such as Haiti. It acts by inhibiting the growth of the malaria parasite in the blood, making it effective for prophylaxis in travelers.

Option A: Metronidazole (Flagyl) is an antibiotic used primarily to treat bacterial and protozoal infections, not for malaria prevention.

Option B: Oprelvekin (Neumega) is a medication that stimulates platelet production and is not related to malaria treatment or prevention.

Option D: Chloroprocaine hydrochloride (Nesacaine) is a local anesthetic used for pain management during surgical procedures, with no role in malaria prophylaxis.

Takeaways: Understanding the role of chloroquine phosphate in malaria prevention is crucial for healthcare providers working in endemic regions, as it requires appropriate prophylactic measures to ensure patient safety and health during travel.

Monitoring liver function tests is essential during estradiol (Estrace) therapy due to the potential for hepatic metabolism alterations and the risk of liver-related side effects.

Option A: Blood pressure monitoring is not a primary concern with estradiol therapy, although it may be affected indirectly. The focus should be on liver function due to the drug's metabolism.

Option B: Blood glucose levels are not directly impacted by estradiol therapy. While hormonal changes can influence glucose metabolism, liver function tests are more critical to monitor.

Option D: Kidney function tests are not specifically indicated for estradiol therapy. The primary concern lies with liver function due to the drug's hepatic processing and potential for liver complications.

Takeaways: Monitoring liver function tests is crucial during hormone replacement therapy with estradiol due to the risk of hepatic side effects and alterations in metabolism, which requires careful assessment of liver health throughout treatment.

Option A: Take the medication at the same time each day to maintain consistent hormone levels. This instruction is crucial for medroxyprogesterone acetate, as consistent timing helps stabilize hormone levels, enhancing the medication's effectiveness in managing endometriosis symptoms and minimizing side effects.

Option B: Discontinuing the medication if side effects occur does not provide a comprehensive approach to managing potential adverse effects. Patients should be advised to report side effects to their healthcare provider for evaluation rather than stopping the medication abruptly.

Option C: Taking the medication with food to prevent gastrointestinal upset is not a necessary instruction for medroxyprogesterone acetate, as it can be taken with or without food. This option does not address the primary concern of maintaining consistent hormone levels.

Option D: Applying the medication once a week is inaccurate as medroxyprogesterone acetate is typically administered orally on a daily basis, not as a topical application. This option misrepresents the standard administration route and frequency for this medication.

Takeaways: Consistent administration of medications like medroxyprogesterone acetate is essential for maintaining stable hormone levels, which is critical for effective treatment of endometriosis and requires patient education on adherence to the prescribed regimen.